Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation

In a cell-based screen of novel anticancer agents, the hit compound 1a which bears a pyrazolo[3,4-d]pyrimidine scaffold exhibited high inhibitory activity against a panel of four different types of tumor cell lines. In particular, the IC50 for A549 cells was 2.24 µM, compared with an IC50 of 9.20 µM...

Full description

Bibliographic Details
Main Authors: Li Yang, Luo-Ting Yu, Ying-Lan Zhao, Ruo Jia, Hai-Yun He, Jin-Ni Zhao, Sheng-Yong Yang
Format: Article
Language:English
Published: MDPI AG 2011-12-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/16/12/10685/